Website banner
Man checking machinery in pharmaceutical laboratory
Nurse and baby
Senior woman in her wheelchair and her daughter

£30 million investment to make UK global leader in innovative cancer research

Patient sample tube

A research programme to pioneer the next generation of cancer therapies has secured £30 million of investment to help develop a new technology called T-cell therapy.

The investment will help to fund clinical trials of this treatment in London. The project is supported by the Government’s National Institute for Health Research (NIHR) and led by University College London (UCL) and University College London Hospitals NHS Foundation Trust (UCLH).

Read more

Featured news

All featured news

Latest funding opportunities

All funding opportunities

Career development opportunities

All career development opportunities

Forthcoming events

All events